ALK-positive lung cancer is one of those weirdly specific corners of cancer biology that sounds obscure until you realize how much it changes treatment. In a small slice of lung cancers, the ALK gene gets fused to another gene, creating a permanently jammed-on growth signal. Instead of treating...
When fingerprinting took off in police work, investigators stopped relying quite so much on vibes and started asking for actual evidence. Lung nodule diagnosis could use a little of that energy. A spot shows up on a scan, everyone squints at it, and the big question lands with all the grace of a...
Take one extremely stubborn lymphoma, add several prior treatments that already failed, fold in a patient’s own T cells after some high-tech genetic meddling, and then pray the whole thing does not boil over into cytokine chaos. That is more or less the recipe behind CAR-T therapy for relapsed or...
For years, stomach bacteria were the backup dancers of cancer biology. Colon microbes got the spotlight, gut health got the merch, and the stomach mostly got typecast as "that place with acid." Now this new Gut review argues that the gastric microbiota may be doing a lot more than loitering near...
Here is the core puzzle piece. The authors found that MMRN1 is highly expressed in leukemia stem cells and can switch on EGFR, a signaling receptor better known from solid tumors than blood cancers. Once that pathway lights up, it helps leukemia cells accumulate sialylglycans - sugar structures...
Hepatocellular carcinoma, or HCC, is the main form of primary liver cancer. It is common, deadly, and often found late, which is a lousy combo for everyone involved (Zheng et al., 2025); (Seyhan et al., 2025). One reason HCC is so hard to treat is that liver tumors do not just grow fast. They also...
If TP53 had a social media bio, it would probably say: "Guardian of the genome. Professional chaos stopper. Currently dealing with nonsense." And in some diffuse large B-cell lymphomas, or DLBCL, that chaos stopper is either broken, overwhelmed, or shoved out of the building entirely.
Cancer cells love glycolysis, which is the biochemical version of living on delivery fries and somehow still making it to work. Even when oxygen is around, many tumors burn through glucose and spit out lactate. In osteosarcoma, that matters because lactate is not just metabolic litter. It changes...
Phrenology once convinced people you could explain the mind by reading bumps on a skull. Cute idea, terrible science. Cancer research has its own version of that mistake when we treat a tumor like it is just a pile of rogue cells and forget the whole miserable workplace around it. This paper argues...
Under the sales pitch, though, sits a serious question. A 2026 Journal of Clinical Oncology commentary with the wonderfully shady title Notably Off Key asks whether the applause around the phase 3 KEYNOTE-689 trial might be a little too loud.[1] Translation: yes, perioperative pembrolizumab helped...
The old ADC story was clean and satisfying: find the cancer cell, dock, enter, release payload, cue dramatic explosion. Tumors, naturally, refused to cooperate. Breast cancers are patchy. One region waves the HER2 flag, another barely mutters it. Some cells internalize drugs nicely, others act like...
What makes a cell itself - its DNA, its habits, or the tiny chemical Post-it notes slapped onto the messages it sends all day? That question sits underneath a new April 22, 2026 review in Molecular Cancer, and the answer is delightfully unsettling: in pancreatic cancer, some of the most important...
This study reads like a casino caper: the tumor thinks it has slipped past security in a very average-looking pancreas, and then an AI model strolls in, checks the grain of the wallpaper, and says, "Cute try." In a new Gut paper, researchers built a system called REDMOD that tries to spot...
If this study were a prestige TV drama, the surgeons would spend an entire season pulling off a heroic finale, only for the villain to sneak back into the same apartment building through the side door. That, in plain English, is the problem with colorectal cancer that has spread to the liver: even...
Breast cancer is not one disease wearing one trench coat. It is a whole cast of subtypes, each with its own habits, mood swings, and talent for causing trouble. That is why immunotherapy has looked brilliant in some patients and shrug-worthy in others. The new review by Shichkin and colleagues maps...
Colorectal cancer used to behave like a stew you forgot on the back burner - mostly a problem that showed up later, after years of simmering. Now it is barging into the kitchen early, showing up in younger adults and in more parts of the world, which is less "grandma's slow recipe" and more "who...
Going once, going twice, sold - not to miracle hype, but to something much rarer in relapsed peripheral T-cell lymphoma: a result that actually makes oncologists put down their coffee and squint at the screen again.
If you learned about lysosomes in school, you probably got the discount version: they're the cell's garbage disposals. Which is true in the same way calling a hospital "a building with chairs" is technically true but emotionally unsatisfying.
Dispatch from inside the liver: the streets are slick with fat, oxidative stress is drifting through the air like tear gas, and the dendritic cells - the immune system's field reporters - are going down before they can get the message to the CD8 T-cell cavalry.
Blood cancers during pregnancy are rare, but rare does not mean simple. It means every decision feels like it was designed by a committee of chaos goblins. The doctor is not just treating a cancer. They are balancing the health of the pregnant patient, the timing of the pregnancy, the type of...